Voyager Therapeutics (VYGR)
(Delayed Data from NSDQ)
$7.82 USD
+0.05 (0.64%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $7.80 -0.02 (-0.26%) 6:06 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
Voyager Therapeutics, Inc. [VYGR]
Reports for Purchase
Showing records 1 - 20 ( 142 total )
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Tracking Tau -- Looking Ahead To Clinical Advancement
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Raise When You Can -- VYGR Announces Secondary Offering
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
New NVS Agreement Generates More Non-Dilutive Capital To Start Year
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Optimized Entry and Exit Levels for VYGR 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Tau Efforts Continue To Tick Closer To Clinic; All Efforts On Track
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
All Cylinders Firing With SOD1 Candidate Selection Nearing
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
With Another Inbound Milestone, 4Q22 Results Largely As Anticipated
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Gimme That GBA1 - VYGR, NBIX Announce Collaborative Parkinson''s Deal
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Putting A Stake In The Ground - Pipeline Prioritization Efforts
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Making It Official - VYGR Appoints Al Sandrock To CEO Role
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L